Benoît Colinet

878 total citations
22 papers, 512 citations indexed

About

Benoît Colinet is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Benoît Colinet has authored 22 papers receiving a total of 512 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pulmonary and Respiratory Medicine, 9 papers in Oncology and 6 papers in Surgery. Recurrent topics in Benoît Colinet's work include Lung Cancer Treatments and Mutations (10 papers), Lung Cancer Diagnosis and Treatment (8 papers) and Lung Cancer Research Studies (6 papers). Benoît Colinet is often cited by papers focused on Lung Cancer Treatments and Mutations (10 papers), Lung Cancer Diagnosis and Treatment (8 papers) and Lung Cancer Research Studies (6 papers). Benoît Colinet collaborates with scholars based in Belgium, France and Luxembourg. Benoît Colinet's co-authors include Sandy Lacombe, William Jacot, Delphine Bertrand, Daurès Jp, Jean-Louis Pujol, Charles Pilette, J.P. Daurès, Jp. Vaerman, M. Decramer and Róbert Kiss and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Benoît Colinet

22 papers receiving 497 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Benoît Colinet Belgium 9 315 193 70 68 50 22 512
Seiichiro Mitani Japan 11 195 0.6× 258 1.3× 56 0.8× 87 1.3× 72 1.4× 69 513
Yutian Lai China 14 424 1.3× 264 1.4× 66 0.9× 259 3.8× 30 0.6× 55 761
Sierra Cheng Canada 12 149 0.5× 210 1.1× 25 0.4× 91 1.3× 31 0.6× 29 454
Kiran Virik Canada 13 112 0.4× 264 1.4× 57 0.8× 63 0.9× 23 0.5× 25 493
Sandrine Lavau‐Denès France 15 183 0.6× 338 1.8× 72 1.0× 97 1.4× 37 0.7× 33 677
V.E.P.P. Lemmens Netherlands 13 216 0.7× 498 2.6× 52 0.7× 268 3.9× 70 1.4× 27 811
Rawad Elias United States 10 159 0.5× 389 2.0× 42 0.6× 48 0.7× 51 1.0× 28 535
P. Zamora Spain 11 123 0.4× 257 1.3× 38 0.5× 66 1.0× 24 0.5× 26 399
Anne S. R. van Lindert Netherlands 10 140 0.4× 109 0.6× 33 0.5× 171 2.5× 44 0.9× 24 450
J.-M. Bréchot France 9 298 0.9× 273 1.4× 108 1.5× 134 2.0× 46 0.9× 34 794

Countries citing papers authored by Benoît Colinet

Since Specialization
Citations

This map shows the geographic impact of Benoît Colinet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benoît Colinet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benoît Colinet more than expected).

Fields of papers citing papers by Benoît Colinet

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Benoît Colinet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benoît Colinet. The network helps show where Benoît Colinet may publish in the future.

Co-authorship network of co-authors of Benoît Colinet

This figure shows the co-authorship network connecting the top 25 collaborators of Benoît Colinet. A scholar is included among the top collaborators of Benoît Colinet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Benoît Colinet. Benoît Colinet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cuppens, Kristof, Ingel Demedts, Lore Decoster, et al.. (2021). Real-World Treatment Patterns, Epidermal Growth Factor Receptor (EGFR) Testing and Outcomes in EGFR-Mutated Advanced Non-small Cell Lung Cancer Patients in Belgium: Results from the REVEAL Study. Drugs - Real World Outcomes. 8(2). 141–152. 8 indexed citations
2.
Tinton, Nicolas, et al.. (2021). Ventral Primary Hernia with Liver Content. SHILAP Revista de lepidopterología. 2021. 1–3. 2 indexed citations
3.
Pilette, Charles, Caroline Dahlqvist, Benoît Colinet, et al.. (2020). Real-Life Study of Mepolizumab in Idiopathic Chronic Eosinophilic Pneumonia. Lung. 198(2). 355–360. 28 indexed citations
4.
Colinet, Benoît, et al.. (2020). Syndrome de Sweet chez une patiente traitée par erlotinib pour un adénocarcinome bronchique. Annales de Dermatologie et de Vénéréologie. 147(3). 202–206. 2 indexed citations
5.
6.
Henin, Pierre, et al.. (2018). Preoperative frailty assessment: a review.. PubMed. 67(4). 157–173. 6 indexed citations
7.
Grève, Jacques De, Jan P. van Meerbeeck, Johan Vansteenkiste, et al.. (2016). Prospective Evaluation of First-Line Erlotinib in Advanced Non-Small Cell Lung Cancer (NSCLC) Carrying an Activating EGFR Mutation: A Multicenter Academic Phase II Study in Caucasian Patients (FIELT). PLoS ONE. 11(3). e0147599–e0147599. 16 indexed citations
8.
Berghmans, Thierry, Jean‐Jacques Lafitte, Arnaud Scherpereel, et al.. (2015). VAC chemotherapy with valproic acid for refractory/relapsing small cell lung cancer: a phase II study. ERJ Open Research. 1(2). 29–2015. 3 indexed citations
9.
10.
Grève, Jacques De, Jan P. van Meerbeeck, Johan Vansteenkiste, et al.. (2011). First-line erlotinib in advanced non-small cell lung cancer (NSCLC) carrying an activating EGFR mutation: A multicentre academic phase II study in caucasian patients (pts) (NCT00339586). Journal of Clinical Oncology. 1 indexed citations
11.
Grève, Jacques De, Jan P. van Meerbeeck, Johan Vansteenkiste, et al.. (2011). First-line erlotinib in advanced non-small cell lung cancer (NSCLC) carrying an activating EGFR mutation: A multicenter academic phase II study in Caucasian patients (pts) (NCT00339586)—FIELT study group.. Journal of Clinical Oncology. 29(15_suppl). 7597–7597. 2 indexed citations
12.
Scherpereel, Arnaud, Thierry Berghmans, J.J. Lafitte, et al.. (2010). Valproate–doxorubicin: promising therapy for progressing mesothelioma. A phase II study. European Respiratory Journal. 37(1). 129–135. 72 indexed citations
13.
Colinet, Benoît, et al.. (2009). Bronchiolite oblitérante avec pneumonie organisée après chimiothérapie de type FOLFOX 4. Revue des Maladies Respiratoires. 27(1). 84–87. 6 indexed citations
14.
Jacot, William, Benoît Colinet, Delphine Bertrand, et al.. (2008). Quality of life and comorbidity score as prognostic determinants in non-small-cell lung cancer patients. Annals of Oncology. 19(8). 1458–1464. 83 indexed citations
15.
Berchier, M.C., Thierry Berghmans, Benoît Colinet, et al.. (2007). European Lung Cancer Working Party Clinical Practice Guidelines. Small Cell Lung Cnacer: IV. Limited disease. 2(2). 74–82. 1 indexed citations
16.
Pilette, Charles, Benoît Colinet, Róbert Kiss, et al.. (2007). Increased galectin-3 expression and intra-epithelial neutrophils in small airways in severe COPD. European Respiratory Journal. 29(5). 914–922. 76 indexed citations
17.
Jennes, Serge, et al.. (2007). Transient selective factor X deficiency in a severely burned child. Burns. 34(7). 1037–1040. 4 indexed citations
18.
Al‐Attar, Nawwar, et al.. (2007). Compact extracorporeal circulation: reducing the surface of cardiopulmonary bypass to improve outcomes.. PubMed. 16. 159–66. 4 indexed citations
19.
Colinet, Benoît, et al.. (2005). A new simplified comorbidity score as a prognostic factor in non-small-cell lung cancer patients: description and comparison with the Charlson's index. British Journal of Cancer. 93(10). 1098–1105. 168 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Seiichiro Mitani Breakdown of academic impact, for papers by Yutian Lai Breakdown of academic impact, for papers by Sierra Cheng Breakdown of academic impact, for papers by Kiran Virik Breakdown of academic impact, for papers by Sandrine Lavau‐Denès Breakdown of academic impact, for papers by V.E.P.P. Lemmens Breakdown of academic impact, for papers by Rawad Elias Breakdown of academic impact, for papers by P. Zamora Breakdown of academic impact, for papers by Anne S. R. van Lindert Breakdown of academic impact, for papers by J.-M. Bréchot
Rankless by CCL
2026